# A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

> **NCT02386072** · — · COMPLETED · sponsor: **Astellas Scientific & Medical Affairs, Inc.** · enrollment: 1524 (actual)

## Conditions studied

- Urinary Bladder Overactive
- Overactive Bladder
- Urinary Bladder Diseases
- Urologic Diseases

## Interventions

- **DRUG:** mirabegron
- **DRUG:** antimuscarinic medication

## Key facts

- **NCT ID:** NCT02386072
- **Lead sponsor:** Astellas Scientific & Medical Affairs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-05
- **Primary completion:** 2017-08-04
- **Final completion:** 2017-08-04
- **Target enrollment:** 1524 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02386072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02386072, "A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02386072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*